Addiction Treatment Within U.S. Correctional Facilities: Bridging the Gap Between Current Practice and Evidence-Based Care
Addiction Treatment Within U.S. Correctional Facilities: Bridging the Gap Between Current Practice and Evidence-Based Care
复制标题
DOI：
10.1080/10550887.2015.1059217
复制
发表时间：
2015-07-03
影响因子：
2.3
通讯作者：
Rich, Josiah D.
中科院分区：
文献类型：
--
作者：
Wakeman, Sarah E.;Rich, Josiah D.
美国在制造囚犯方面领先世界。这种监禁的流行主要是由于“禁毒战争”，这导致了对成瘾疾病的刑事定罪。一半的囚犯患有活跃的药物使用障碍，但少数人接受正式治疗。阿片类激动剂维持是阿片类药物使用障碍最有效的治疗方法之一。维持治疗减少了非法阿片类药物的使用，犯罪，累犯和成本，但很少有惩教机构提供这种挽救生命的治疗。增加获得阿片类激动剂维持以及重新审查药物政策是必要的，以解决这一昂贵和病态的监禁流行病。
The United States leads the world in creating prisoners. This epidemic of incarceration is largely due to the "War on Drugs," which has resulted in criminalization of the disease of addiction. Half of prisoners have an active substance use disorder yet a minority receives formal treatment. Opioid agonist maintenance is among the most effective treatments for opioid use disorder. Maintenance treatment reduces illicit opioid use, crime, recidivism, and cost, yet few correctional facilities provide this lifesaving treatment. Increased access to opioid agonist maintenance as well as reexamination of drug policy is necessary to address this costly and morbid incarceration epidemic.